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Bacteremia associated with tunneled dialysis catheters: Com- Tunneled dialysis catheters placed in a central vein are
parison of two treatment strategies. used frequently in hemodialysis patients as a temporary
Background. Tunneled dialysis catheters are often used for vascular access until an arteriovenous (AV) fistula or atemporary vascular access in hemodialysis patients, but are
polyfluoroethylene (PTFE) graft is ready to use [1]. Incomplicated by frequent systemic infections. The treatment of
addition, dialysis catheters are used as a permanent vas-bacteremia associated with infected tunneled catheters re-
quires both antibiotic therapy and catheter replacement. We cular access in some patients who have exhausted all
compared the outcomes of two treatment strategies for cathe- options for placement of a fistula or graft. A large pro-
ter-associated bacteremia: exchange of the existing catheter portion of hemodialysis patients in the United Stateswith a new one over a guidewire versus catheter removal with
dialyze through a catheter at any time. In a recent survey,delayed replacement.
nearly 20% of the prevalent patients required a dialysisMethods. We retrospectively analyzed the outcomes of all
cases of tunneled dialysis catheter-associated bacteremia dur- catheter for vascular access [2]. As compared with fistulas
ing a two-year period. The infection-free survival time of the and grafts, tunneled dialysis catheters offer the advan-
subsequent catheter was evaluated in two groups of patients:
tage of ease of placement and the ability to be usedgroup A (31 catheters), exchange of the existing infected cathe-
immediately for dialysis. However, they suffer from sev-ter with a new catheter over a guidewire, and group B (38
catheters), removal of the infected catheter followed by de- eral disadvantages, including poor blood flow [3], fre-
layed catheter replacement 3 to 10 days later. Patients in both quent thrombosis and infection [3–5], risk of central vein
groups received three weeks of systemic antibiotic therapy. stenosis [6–8], and limited longevity [5, 9].
Cox proportional hazard models were used to evaluate the
Infections are the most serious complication of tun-factors predictive of infection-free survival time of the replace-
neled dialysis catheters. The frequency of catheter-asso-ment catheter.
Results. On univariate proportional hazard regression analy- ciated bacteremia has been about two to four per 1000
sis, the infection-free survival time of the replacement catheter patient-days in a number of studies, equivalent to 0.7 to
was similar for groups A and B (P 5 0.72), whereas the hazard 1.5 per catheter year [5, 10–12]. In contrast, the frequency
of infection was significantly greater for patients with hypoal-
of infections is approximately 0.2 per patient-year forbuminemia (serum albumin , 3.5 g/dL), as compared with
AV grafts and 0.05 per patient-year for AV fistulas [13].patients with a normal serum albumin (hazard ratio 2.81, 95%
CI, 1.21, 6.53, P 5 0.016). The infection-free survival time was Moreover, catheter-associated bacteremia often results
not affected by patient age, sex, diabetic status, or type of in serious systemic infections, including endocarditis, os-
organism (gram-positive coccus vs. gram-negative rod). teomyelitis, epidural abscess, septic arthritis, and even
Conclusions. The infection-free survival time associated
death [11]. Treatment of catheter-associated bacteremiawith the subsequent catheter is similar for the two treatment
with systemic antibiotics without catheter removal is notstrategies. However, exchanging the catheter for a new one
over a guidewire minimizes the number of separate procedures usually effective. Only 22 to 32% of tunneled catheters
required by the patient. Hypoalbuminemia is the major risk can be salvaged without catheter removal [5, 10, 11, 14].
factor for recurrent bacteremia in the replacement catheter. Moreover, attempting to salvage the infected catheter
with antibiotics alone incurs the risk of serious systemic
complications, including endocarditis and epidural ab-Key words: hemodialysis, dialysis catheter, infection, hypoalbumi-
nemia, vascular access. scess [15]. On the other hand, the removal of the dialysis
catheter creates a short-term vascular access hardshipReceived for publication October 6, 1999
until a new catheter can be placed, frequently necessitat-and in revised form November 17, 1999
Accepted for publication December 23, 1999 ing the insertion of one or more femoral dialysis cathe-
ters and requiring utilization of an inpatient dialysis unit.Ó 2000 by the International Society of Nephrology
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Several recent observational studies have reported that tamicin) was initiated immediately after obtaining blood
cultures from a peripheral vein. Patients with clinicalexchanging infected dialysis catheters over a guidewire,
in combination with systemic antibiotics, results in suc- sepsis (some combination of high fever, persistent shak-
ing chills, or hypotension) were hospitalized for furthercessful resolution of the infection [12, 16, 17]. Unfortu-
nately, none of these studies reported a concurrent con- management, whereas those with milder symptoms (low
grade fever and stable blood pressure) were managed astrol group for comparison of the outcomes.
The present study retrospectively analyzed the out- outpatients. The dialysis catheter was removed promptly
(within 24 to 48 h) if there was an exit site infection,comes of the replacement catheters following all epi-
sodes of dialysis catheter-associated bacteremia during severe sepsis (persistent shaking chills or hypotension)
in spite of antibiotics, or persistent fever 48 hours aftera two-year period. We compared two treatment strate-
gies at our institution: exchange of the infected catheter the initiation of antibiotic therapy. In the remaining cases
of catheter-associated bacteremia, one of two treatmentwith a new one over a guidewire versus removal of the
infected catheter followed by delayed placement of a strategies was followed, at the discretion of the nephrolo-
gist. The first strategy (group A) consisted of replacingnew catheter 3 to 10 days later. Both patient groups
received systemic antibiotics for three weeks. We used the infected dialysis catheter with a new one over a guide-
wire within a few days once the bacteremia was clinicallyprospective, computerized records [18] to track the cath-
eter events. resolved (absence of fever or chills). Documentation of
negative blood cultures following antibiotic administra-
tion was not required prior to catheter replacement. The
METHODS
second strategy (group B) consisted of removal of the
Patient population dialysis catheter within 1 to 2 days of the onset of clinical
symptoms and placement of a new tunneled dialysis cath-The University of Alabama at Birmingham (UAB)
provides chronic dialysis to approximately 350 in-center eter 3 to 10 days later. In the interim, these patients were
dialyzed with a femoral dialysis catheter. Patients in bothhemodialysis patients. About 15% of the prevalent pa-
tients dialyze with tunneled dialysis catheters. The demo- groups A and B received three weeks of systemic antibi-
otic therapy, which was tailored to the culture and sensi-graphics of the patients dialyzing with catheters are as
follows: 26% of the patients are age 65 or older; 51% tivities reported. The differences in the strategies se-
lected by the individual nephrologists were largely dueof the patients are female; 84% of the patients are black,
and 16% are white; 41% of the patients have diabetes. to their subjective impressions regarding the severity of
clinical sepsis.All patient hospitalizations, surgical procedures, and ra-
diologic procedures are done at UAB Hospital. The vast
Data collectionmajority of dialysis catheter procedures are performed
by interventional radiology. A full-time dialysis access coordinator scheduled all of
the dialysis access procedures and maintained a computer-
Dialysis catheter placement and management ized record of all procedures performed [18]. Consent
for review of the patients’ medical records for researchDouble-lumen cuffed dialysis catheters were placed
by one of four experienced interventional radiologists. purposes was obtained from the UAB Institutional Re-
view Board. Removal of infected dialysis catheters wasAll catheters were placed through the internal jugular
vein using ultrasound guidance. The tip of the catheter performed by either interventional radiology or access
surgery, whereas exchange of infected catheters or place-was positioned in the right atrium using fluoroscopy,
with the distal end tunneled through the subcutaneous ment of new catheters was performed by one of four
experienced interventional radiologists. We identified alltissue in the anterior chest wall and the Dacron cuff
positioned within the tunnel. Aseptic techniques were cases of dialysis catheter-associated bacteremia occurring
during the two-year period between January 1, 1997,used by the dialysis nurses to access the catheters for
hemodialysis. Catheter thrombosis was treated by instill- and December 31, 1998. If a patient had more than one
episode of catheter-associated bacteremia during theing 5000 units of urokinase into each lumen [4]. When
this maneuver failed to re-establish patency, the catheter study period, only the first infection was included in
the analysis. We excluded cases in which a replacementwas replaced over a guidewire with a new dialysis cathe-
ter, utilizing the same subcutaneous tunnel. catheter was not inserted within 10 days of removal of
the infected catheter. (In most instances, this was due
Management of dialysis catheter-associated bacteremia to having a permanent access ready to use, persistent
fever after catheter removal, or patient death.) The fol-Infection was suspected whenever patients with a dial-
ysis catheter developed fevers or chills, in the absence lowing demographic and clinical information was col-
lected for each patient: age, sex, race, diabetic status,of an alternative source of infection. Treatment with
empiric broad spectrum antibiotics (vancomycin and gen- serum albumin, and the organism grown from the blood
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Table 1. Baseline clinical features of patients with catheter-associated bacteremia
Group A Group B P value All catheters
Number of catheters 31 38 69
Age (mean6SD) 52616 52616 52616
Age .65 years 8 (26%) 10 (26%) 0.96 18 (26%)
Age ,65 years 23 (74%) 28 (74%) 51 (74%)
Sex
Male 13 (42%) 21 (55%) 0.27 34 (49%)
Female 18 (58%) 17 (45%) 35 (51%)
Race
Black 26 (84%) 32 (84%) 0.97 58 (84%)
White 5 (16%) 6 (16%) 11 (16%)
Diabetes
Yes 11 (35%) 17 (45%) 0.44 28 (41%)
No 20 (65%) 21 (55%) 41 (59%)
Type of organism
Gram-positive coccus 22 (71%) 22 (58%) 0.26 44 (64%)
Gram-negative rod 9 (29%) 16 (42%) 25 (36%)
Serum albumina
,3.0 m/dL 11 (38%) 9 (25%) 0.48 20 (31%)
3.0–3.9 m/dL 15 (52%) 21 (58%) 36 (55%)
.4.0 m/dL 3 (10%) 6 (17%) 9 (14%)
Serious complications
Yes 7 (23%) 6 (16%) 0.47 13 (19%)
No 24 (77%) 32 (84%) 56 (81%)
Outcome of the replacement catheter
Infection 16 (52%) 16 (42%) 0.86 32 (46%)
Elective removal 5 (16%) 7 (18%) 12 (17%)
Malfunction 8 (26%) 11 (29%) 19 (28%)
Death 2 (6%) 4 (10%) 6 (9%)
Groups are defined as: Group A, exchange of catheter over guidewire; Group B, removal of catheter with delayed placement of new catheter.
aValues missing in four cases
cultures. Finally, each patient’s medical records was re- of the significance of several independent variables in the
viewed to evaluate for serious complications associated presence of each other. Hazard ratios and the associated
with catheter-associated bacteremia. 95% confidence intervals were computed. Survival distri-
We then evaluated the infection-free survival time of butions were plotted using the Kaplan–Meier method.
the replacement catheter. The longevity of each replace-
ment catheter (groups A and B) was calculated as the
RESULTSnumber of days from catheter placement (or exchange)
We analyzed the outcomes of all cases of dialysis cath-and catheter removal. The indication for catheter re-
eter-associated bacteremia during the two-year periodmoval was categorized as infection, malfunction (throm-
from January 1, 1997, to December 31, 1998. After ex-bosis or poor flow), or elective (permanent vascular ac-
cluding patients who did not receive a replacement cathe-cess ready to use). When urokinase was unsuccessful in
ter within 10 days of catheter removal, we were left withrestoring blood flow, the patient was referred to interven-
69 cases of documented catheter-associated bacteremia.tional radiology for an elective exchange. We also deter-
The age, sex, racial distribution, and frequency of diabe-mined the organism responsible for the infections in the
tes among this group of patients (Table 1) were similarreplacement catheters.
to that in the prevalent dialysis population at UAB.
Statistical analysis Approximately two thirds of the patients were infected
with a gram-positive organism (mostly Staph aureus orDescriptive statistics were used to summarize the sam-
Staph epi), and the remainder had gram-negative infec-ple data. The time from catheter replacement (exchange
tions. Serious complications occurred in 19% of all epi-or delayed replacement) until recurrent infection was
sodes of catheter-associated bacteremia. These includedcalculated. Survival analysis techniques were used to
endocarditis (2 patients), septic arthritis (3), septic em-model infection-free survival time. Patients whose cathe-
boli to the brain (1), and severe sepsis requiring hospital-ter malfunctioned was electively removed (permanent
ization in the intensive care unit (7).vascular access ready to use) or who died with a function-
The patients were classified retrospectively into twoing catheter were considered censored. Univariate Cox
groups according to the clinical management of the cath-proportional hazard models were fit. Multivariable Cox
proportional hazard models allowed for the evaluation eter. Group A patients had the infected catheter replaced
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Table 2. Univariate proportional hazard regression analysis of
clinical factors as predictors of infection-free catheter survival
Hazard
Variable ratio 95% C.I. P value
Treatment group 0.88 (0.43, 1.79) 0.72
Serum albumin
(,3.5 vs. $3.5 g/dL) 2.81 (1.21, 6.53) 0.016
Age 1.00 (0.98, 1.02) 0.74
Sex 1.49 (0.73, 3.05) 0.27
Race 0.64 (0.22, 1.84) 0.41
Diabetic status 1.72 (0.83, 3.58) 0.15
Type of organism 1.60 (0.69, 3.73) 0.28
Fig. 2. Life-table analysis (Kaplan–Meier survival curves) for infection-
free survival of the replacement catheter in patients with hypoalbumi-
nemia (serum albumin , 3.5 g/dL) versus patients with a normal serum
albumin, P 5 0.016).
with a normal serum albumin (Table 2 and Fig. 2). The
infection-free survival time was not significantly affected
by patient age, sex, race, diabetic status, or type of infec-
tive organism (Table 2). Finally, using multivariable step-
wise proportional hazard regression analysis, only low
serum albumin and male sex had increased hazard of
catheter infection (this was true whether serum albumin
was treated as a categorical or continuous variable).Fig. 1. Life-table analysis (Kaplan–Meier survival curves) for infection-
free survival of the replacement catheter in patients whose dialysis Among patients whose initial infection was with a
catheter was replaced with one of two strategies (group A, replacement gram-positive organism, the second infection was with
over a guidewire; group B, removal of the catheter with delayed replace-
another gram-positive organism in 88% of the cases. Inment 3 to 10 days later, P 5 0.72).
contrast, following a gram-negative, catheter-associated
bacteremia, the next infection was equally likely to be
with a gram-positive or gram-negative organism.
with a new one over a guidewire. Group B patients had
their infected dialysis catheter removed, with delayed
DISCUSSIONplacement of a new catheter 3 to 10 days later. Patients
in both treatment groups were treated with three weeks We observed a high frequency of infections of the
replacement dialysis catheter following an initial episodeof systemic antibiotics. The patients in both groups were
similar to each other in terms of age, sex and race distri- of catheter-associated bacteremia. Although this was not
a randomized study, the patients in groups A and B werebution, frequency of diabetes, type of infective organism,
and severity of infection, as inferred from the frequency closely matched in terms of their clinical characteristics
(Table 1). The infection-free survival time was similarof serious complications (Table 1).
Of the 69 replacement dialysis catheters, 32 had to be whether the initial dialysis catheter was exchanged with
a new one over a guidewire (group A) or whether it wasremoved because of a second infection (Table 1). In
addition, 19 catheters were replaced because of malfunc- removed with delayed placement of a new catheter 3 to
10 days later (group B). The former strategy requires ation (thrombosis or poor flow). Twelve were removed
electively because the patient had a fistula or graft that single, relatively brief procedure by interventional radi-
ology, without an interruption of the outpatient hemodi-was ready to use, and six were patent and uninfected at
the time of patient death or date of study analysis. On alysis schedule. In contrast, the second strategy involves
two separate radiologic procedures, at least one femoralunivariate proportional hazard regression analysis of in-
fection-free catheter survival time, there was no signifi- dialysis catheter placement, and at least one dialysis ses-
sion in the inpatient dialysis unit. Moreover, the removalcant difference between patients in groups A and B (Ta-
ble 2 and Fig. 1). Patients with hypoalbuminemia (serum of an infected catheter carries the risk of losing a poten-
tial vascular access site as a result of occlusion of a centralalbumin , 3.5 g/dL) had a higher hazard of a second
episode of catheter-associated bacteremia than patients vein. Thus, from the perspective of cost-benefit analysis,
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